TEACHERS ADVISORS, LLC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 212 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.3%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$5,133,000
+16.6%
45,887
+5.1%
0.01%0.0%
Q4 2018$4,402,000
-59.5%
43,674
-49.2%
0.01%
-14.3%
Q3 2018$10,872,000
+210.3%
86,036
+106.0%
0.01%
+75.0%
Q2 2018$3,504,000
+191.0%
41,764
+113.4%
0.00%
+100.0%
Q1 2018$1,204,000
+5.2%
19,5750.0%0.00%
+100.0%
Q4 2017$1,144,000
+3.9%
19,575
+3.2%
0.00%0.0%
Q3 2017$1,101,000
-50.6%
18,976
+3.0%
0.00%
-66.7%
Q2 2017$2,231,000
+24.3%
18,430
+16.1%
0.00%0.0%
Q1 2017$1,795,000
+7.2%
15,871
+3.0%
0.00%0.0%
Q4 2016$1,674,000
-27.7%
15,410
+9.5%
0.00%
-25.0%
Q3 2016$2,316,000
+17.7%
14,071
+2.0%
0.00%
+33.3%
Q2 2016$1,968,000
+9.6%
13,792
-1.3%
0.00%0.0%
Q1 2016$1,796,000
-13.9%
13,9770.0%0.00%
-25.0%
Q4 2015$2,087,000
-79.7%
13,977
-77.4%
0.00%
-81.0%
Q3 2015$10,274,000
-4.6%
61,943
+38.9%
0.02%
+5.0%
Q2 2015$10,767,000
+297.2%
44,606
+364.0%
0.02%
+300.0%
Q1 2015$2,711,000
+98.8%
9,613
+10.0%
0.01%
+66.7%
Q4 2014$1,364,000
-28.7%
8,741
+8.2%
0.00%
-25.0%
Q3 2014$1,912,000
+2.6%
8,080
+2.6%
0.00%0.0%
Q2 2014$1,863,000
-71.1%
7,872
-59.7%
0.00%
-71.4%
Q1 2014$6,444,000
-12.2%
19,539
-81.8%
0.01%
-17.6%
Q4 2013$7,338,000
+210.9%
107,468
+214.3%
0.02%
+183.3%
Q3 2013$2,360,000
+536.1%
34,188
+312.8%
0.01%
+500.0%
Q2 2013$371,0008,2820.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders